A novel phospholipase C inhibitor U73122, inhibits phospholipase C-independent processes in rat luteal cells.
Abayasekara
R E
RE
Institute of Zoology, Regent's Park, London.
Flint
A P
AP
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002478:Cells, Cultured; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D003338:Corpus Luteum / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism*; D004963:Estrenes / Q000494:pharmacology; D005260:Female; D006064:Gonadotropins, Equine / Q000494:pharmacology; D006888:Hydroxycholesterols / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000494:pharmacology; D011284:Pregnenolone / Q000494:pharmacology; D011374:Progesterone / Q000378:metabolism* / Q000494:pharmacology; D011760:Pyrrolidinones / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000187:drug effects; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors*
D006063:Chorionic Gonadotropin; D004963:Estrenes; D006064:Gonadotropins, Equine; D006888:Hydroxycholesterols; D011760:Pyrrolidinones; C060229:1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione; C074854:U 73343; C003585:22-hydroxycholesterol; D011374:Progesterone; D003994:Bucladesine; D011284:Pregnenolone; D007986:Luteinizing Hormone; D000242:Cyclic AMP; D010738:Type C Phospholipases